NEONATAL SEIZURES
Clinical trials for NEONATAL SEIZURES explained in plain language.
Never miss a new study
Get alerted when new NEONATAL SEIZURES trials appear
Sign up with your email to follow new studies for NEONATAL SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for newborn seizures: levetiracetam shows promise in early trial
Symptom relief CompletedThis study tested the safety and correct dose of levetiracetam, a seizure medicine, in 18 full-term newborns who had seizures due to a lack of oxygen around birth. The goal was to see if it could reduce seizure activity on brain monitoring without causing serious side effects. Th…
Matched conditions: NEONATAL SEIZURES
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated May 26, 2026 12:01 UTC
-
Newborn seizure drug shows promise: faster, safer option found
Symptom relief CompletedThis study tested whether levetiracetam works better and safer than standard drugs (phenobarbitone) for stopping seizures in newborns. 260 babies aged 0-28 days with seizures were randomly assigned to receive either levetiracetam or standard treatment. The goal was to see how qui…
Matched conditions: NEONATAL SEIZURES
Phase: NA • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Symptom relief
Last updated May 26, 2026 12:01 UTC
-
New wireless EEG monitor tested in tiny patients
Knowledge-focused CompletedThis study tested a portable, wireless EEG monitor called NeuroBell on 17 full-term newborns who already needed brain monitoring. The goal was to see if the new device records brain signals as well as standard monitors. The study was observational, meaning no treatment was given,…
Matched conditions: NEONATAL SEIZURES
Sponsor: University College Cork • Aim: Knowledge-focused
Last updated May 26, 2026 12:10 UTC